When preventing HIV, bacteria in the vagina matter

Some microbes appear to break down drug in prophylactic gel, making it less effective

applicator

DOSE OF GEL  Women use an applicator (shown) to self-administer a vaginal gel containing the HIV-prevention drug tenofovir. Vaginal bacteria affect how well the drug works, a new study suggests.

CAPRISA

This article is only available to Science News subscribers.

Subscribers, enter your e-mail address to access our archives.

Not a subscriber?

Science News is a nonprofit.

Support us by subscribing now.

More Stories from Science News on Health & Medicine

From the Nature Index

Paid Content